N-(tert-Butoxycarbonyl)-S-benzyl-L-cysteine>98.0%(HPLC)(T)5g

(R)-tert-Butyl 3-(5-aminopyridin-2-yloxy)pyrrolidine-1-carboxylate, 95.0%, 1g

7-BROMO-5-CHLORO-INDAN-1-ONE, 95%, 100mg

7-Amino-N,N-dimethylbenzo[c][1,2,5]oxadiazole-4-sulfonamide, 98%, 100mg

2-(Methylsulfinyl)phenylboronic acid, 97.0%, 1g

2-Bromo-1-o-tolyl-propan-1-one, 95.0%, 1g

N-bromosuccinimide, min. 98%, for synthesis, 100 g, glass packaging

(2S,3S)-METHYL 3-HYDROXYPYRROLIDINE-2-CARBOXYLATE HCL, 95.0%, 500mg

3-Fluoro-2-hydroxypyridine, 95.0%, 10g

6-Chloro-[1,2,4]triazolo[1,5-a]pyridin-2-amine, 95.0%, 1g

4-(3-(4-Fluorophenyl)ureido)benzenesulfonamide, 98%, 100mg

Ethyl 2-((tert-butoxycarbonyl)amino)-1H-indole-3-carboxylate, 95+%, 250mg

1-(2-Methoxyethyl)-6-oxo-1,6-dihydropyridine-3-carboxylic acid, 100mg